ES2358146B1 - Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis. - Google Patents

Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis. Download PDF

Info

Publication number
ES2358146B1
ES2358146B1 ES200930890A ES200930890A ES2358146B1 ES 2358146 B1 ES2358146 B1 ES 2358146B1 ES 200930890 A ES200930890 A ES 200930890A ES 200930890 A ES200930890 A ES 200930890A ES 2358146 B1 ES2358146 B1 ES 2358146B1
Authority
ES
Spain
Prior art keywords
maintenance
hematopoiesis
stem cell
cells
positive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200930890A
Other languages
English (en)
Other versions
ES2358146A1 (es
Inventor
Simon Mendez Ferrer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUNDACION PUBLICA ANDALUZA PARA LA GESTION de la INVESTIGACION EN SALUD EN SEVILLA
Original Assignee
FUNDACION PUBLICA ANDALUZA PARA LA GESTION de la INVESTIGACION EN SALUD EN SEVILLA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUNDACION PUBLICA ANDALUZA PARA LA GESTION de la INVESTIGACION EN SALUD EN SEVILLA filed Critical FUNDACION PUBLICA ANDALUZA PARA LA GESTION de la INVESTIGACION EN SALUD EN SEVILLA
Priority to ES200930890A priority Critical patent/ES2358146B1/es
Priority to PCT/ES2010/070682 priority patent/WO2011048253A1/es
Priority to EP10824506.9A priority patent/EP2492341A4/en
Priority to US13/503,137 priority patent/US20130022582A1/en
Publication of ES2358146A1 publication Critical patent/ES2358146A1/es
Application granted granted Critical
Publication of ES2358146B1 publication Critical patent/ES2358146B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0664—Dental pulp stem cells, Dental follicle stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0666—Mesenchymal stem cells from hair follicles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C12N5/0675—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis.#La presente invención se refiere al uso de al menos una célula madre multipotencial aislada para el mantenimiento de la hematopoyesis in vitro donde preferiblemente dicha célula madre multipotencial es una célula madre mesenquimal o más preferiblemente dicha célula madre mesenquimal es una célula mesenquimal capaz de expresar la proteína nestina. Si la célula madre multipotencial procede de un embrión humano, ésta se obtiene sin destruir dicho embrión. La presente invención también se refiere al uso de cualquiera de las células madre descritas anteriormente para la fabricación de un medicamento para el mantenimiento de la hematopoyesis de un mamífero, o para la prevención y/o el tratamiento de al menos una enfermedad asociada con una disfunción del mantenimiento de la hematopoyesis de un mamífero. Asimismo, la presente invención también se refiere a un método para el mantenimiento de la hematopoyesis in vitro o a un método para evaluar la capacidad hematopoyética de un mamífero.
ES200930890A 2009-10-22 2009-10-22 Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis. Expired - Fee Related ES2358146B1 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ES200930890A ES2358146B1 (es) 2009-10-22 2009-10-22 Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis.
PCT/ES2010/070682 WO2011048253A1 (es) 2009-10-22 2010-10-22 Células multipotenciales nestina positivas
EP10824506.9A EP2492341A4 (en) 2009-10-22 2010-10-22 PLURIPOTENT CELLS OF POSITIVE NESTINE
US13/503,137 US20130022582A1 (en) 2009-10-22 2010-10-22 Multipotent nestin-positive cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200930890A ES2358146B1 (es) 2009-10-22 2009-10-22 Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis.

Publications (2)

Publication Number Publication Date
ES2358146A1 ES2358146A1 (es) 2011-05-06
ES2358146B1 true ES2358146B1 (es) 2012-03-23

Family

ID=43880330

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200930890A Expired - Fee Related ES2358146B1 (es) 2009-10-22 2009-10-22 Uso de células mesenquimales nestina positivas para el mantenimiento de la hematopoyesis.

Country Status (4)

Country Link
US (1) US20130022582A1 (es)
EP (1) EP2492341A4 (es)
ES (1) ES2358146B1 (es)
WO (1) WO2011048253A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104508124B (zh) 2011-07-06 2017-11-17 细胞治疗有限公司 中胚层谱系祖细胞
EP3302065A4 (en) * 2015-05-28 2019-04-10 Celularity, Inc. PLACENTIAL STEM CELLS FOR RECOVERING THE REGENERATIVE MOTOR, CORRECTING PROTEOMIC DEFECTS AND EXTENDING THE LIFE
WO2017027512A1 (en) * 2015-08-13 2017-02-16 Teva Pharmaceutical Industries Ltd. Use of laquinimod to treat traumatic brain injury

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020123143A1 (en) * 1997-08-22 2002-09-05 Jean Toma Multipotent stem cells from peripheral tissues and uses thereof
US20090053182A1 (en) * 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same

Also Published As

Publication number Publication date
ES2358146A1 (es) 2011-05-06
EP2492341A1 (en) 2012-08-29
US20130022582A1 (en) 2013-01-24
EP2492341A4 (en) 2013-09-11
WO2011048253A1 (es) 2011-04-28

Similar Documents

Publication Publication Date Title
Dupin et al. Neural crest progenitors and stem cells: from early development to adulthood
MX2013010343A (es) Composicion y metodos para el transplante de microbiota de colon.
BRPI1013771A2 (pt) "células-tronco mesenquimais projetadas e método de uso das mesmas para tratar tumores."
EA201391154A2 (ru) Способы и композиции для нацеливания на адипоциты у млекопитающих
EP3805762C0 (en) IMAGING AND EVALUATION OF EMBRYOS, OOCYTES AND STEM CELLS
BRPI0814894A2 (pt) Diferenciação de células-tronco embrionárias de ser humano.
WO2015026235A3 (en) Production of probiotics by in vitro enrichment of beneficial microorganisms from human or animal microbiota
AR081166A1 (es) Angiogenesis por el uso de celulas madre placentarias
AR106768A1 (es) Composiciones que comprenden cepas bacterianas
WO2011139357A8 (en) Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
GT201200313A (es) 5-fluoro-1h-pirazolopiridinas sustituidas y su uso
PE20110399A1 (es) Tratamiento de la apoplejia utilizando celulas placentarias aisladas
ECSP13012379A (es) Pirimidinas y triazinas condensadas y su uso
HN2011001195A (es) Compuestos que expanden las celulas madre hematopoieticas
WO2009017655A3 (en) Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance p or an analog thereof
CR20110470A (es) Proteínas de union a il-17
GT201400033A (es) Pirimidinas anilladas sustituidas y uso de las mismas
CL2012001950A1 (es) Uso de una cepa bacteriana probiotico en la fabricacion de un medicamento o composicion nutricional en humanos o animales para alterar los patrones del sueño
ES2571105T3 (es) Modulador
PL2192911T3 (pl) Roślinny ekstrakt z konopi ubogich w THC do leczenia chorób
EP2879682A4 (en) TREATMENT OF PULMONARY ARTERIAL HIGH PRESSURE WITH MESENCHYMAL STEM CELLS
MX339709B (es) Antagonistas de wnt y metodos de tratamiento y analisis.
CL2013002934A1 (es) Polimeros conjugados analogos de prostaglandinas; metodo de preparacion; implante y uso en el tratamiento del glaucoma.
MX2019006048A (es) Unidad de tejido nervioso y utilizacion de una unidad de este tipo para la implantacion en el sistema nervioso de un mamifero.
ES2571991T3 (es) Procedimientos para tratar y/o revertir enfermedades y/o trastornos neurodegenerativos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2358146

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20120323

FD2A Announcement of lapse in spain

Effective date: 20180924